Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

12.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.8K
Blood Transfusion01:15

Blood Transfusion

3.0K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
3.0K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

100
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
100
Viral Meningitis01:18

Viral Meningitis

191
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
191
Arboviral Encephalitis01:25

Arboviral Encephalitis

54
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
54
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

93
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
93

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cold comfort pharm.

BMJ case reports·2025
Same author

Accuracy of a history of blood donation from surrogate witnesses: data from the UK TMER study.

Vox sanguinis·2018
Same author

Creutzfeldt-Jakob disease and blood transfusion safety.

Vox sanguinis·2018
Same author

Acute malaria in a repeat blood donor.

Transfusion medicine (Oxford, England)·2017
Same author

Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors.

Vox sanguinis·2016
Same author

Transfusion in adults: 10-year survival of red cell, plasma and platelet recipients following transfusion.

Transfusion medicine (Oxford, England)·2016

Related Experiment Video

Updated: Apr 28, 2026

Prion Safety Laboratory Swipe Test
06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

1.4K

Variant CJD and blood transfusion: are there additional cases?

L R R Davidson1, C A Llewelyn, J M Mackenzie

  • 1National CJD Research & Surveillance Unit, Western General Hospital, Edinburgh, UK.

Vox Sanguinis
|June 12, 2014
PubMed
Summary

This study investigated variant Creutzfeldt-Jakob disease (vCJD) transmission via blood transfusion. While some cases suggest transfusion risk, the evidence is weak, and most vCJD cases lack transfusion history, ruling out widespread undetected transmission.

Keywords:
bloodtransfusionvariant Creutzfeldt-Jakob disease

More Related Videos

In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus
10:21

In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus

Published on: December 2, 2012

20.0K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.1K

Related Experiment Videos

Last Updated: Apr 28, 2026

Prion Safety Laboratory Swipe Test
06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

1.4K
In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus
10:21

In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus

Published on: December 2, 2012

20.0K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.1K

Area of Science:

  • Neuroscience
  • Epidemiology
  • Public Health

Background:

  • Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegenerative disorder.
  • Blood transfusion is a potential route of vCJD transmission.
  • Understanding transfusion transmission is crucial for public health safety.

Purpose of the Study:

  • To compare demographics and clinical phenotypes of vCJD cases with confirmed, suspected, and no blood transfusion history.
  • To assess the likelihood of vCJD transmission through blood products.
  • To identify potential differences that may indicate further transfusion-transmitted cases.

Main Methods:

  • Retrospective analysis of vCJD cases in the UK.
  • Tracing blood transfusion records for vCJD patients.
  • Investigating donor records for vCJD development.
  • Comparing clinical and demographic data across patient groups.

Main Results:

  • Fifteen vCJD cases with transfusion history were identified; records were available for ten.
  • Nine transfusion recipients had a mean age of 42.9 years at symptom onset.
  • Three cases were linked to transfusion-transmitted vCJD; six were not.
  • Donors in non-linked cases were not known to have vCJD, though some have died from other causes.
  • Two transfusion-transmitted cases met probable vCJD criteria only post-mortem, with atypical features.

Conclusions:

  • The possibility of vCJD transmission through blood transfusions from asymptomatic donors exists.
  • Evidence for widespread, unrecognized transfusion transmission is weak.
  • The lack of transfusion history in most vCJD cases suggests it is not a primary transmission route for the majority.